BJMO - 2020, issue Special, october 2020
prof. dr. Axel Bex
Over the course of 2020, updates were presented of several pivotal randomised controlled trials in renal cell carcinoma (RCC). During the 2020 annual BMUC meeting, Prof. Dr. Axel Bex (UCL Division of Surgery and Interventional Science, London, UK. The Netherlands Cancer Institute, Amsterdam, The Netherlands) provided an overview of the most important novelties in the field of RCC and gave us a look into the future.
Read moreTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.